Status:
RECRUITING
Early Versus Delayed Cholecystectomy After Percutaneous Cholecystostomy in Moderate and Severe Cholecystitis (ESCAPE)
Lead Sponsor:
Yada Suwan
Collaborating Sponsors:
Chiang Mai University
Lampang Hospital
Conditions:
Acute Cholecystitis
Percutaneous Cholecystostomy
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Abstract: Acute cholecystitis (AC) is typically managed according to the 2018 Tokyo Guidelines, with treatment strategies determined by the severity of the disease, patient comorbidities, and hospita...
Eligibility Criteria
Inclusion
- The patients are diagnosed moderate or severe from of acute cholecystitis according to Tokyo Guideline 2018.
- PCC insertion was performed by body interventionists or surgeons.
- Laparoscopic cholecystectomy will be performed in Maharaj Nakorn Chiang Mai Hospital, Lampang Hospital and Phrae Hospital.
- Age equal or more than 20 years-old
Exclusion
- The patients that suspected CBD stone and need to undergo EUS / ERCP.
- Coincidence perihepatic abscess or liver abscess
- The patients with active or severe underlying disease, whom specialists suggest to postpone an operation.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT07161960
Start Date
July 1 2025
End Date
November 1 2027
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Chiang Mai University 110 Inthawarorot Road, Sri Phum, Mueang, Chiang Mai 50200, Thailand
Chiang Mai, Thailand, 50200